Add BrightSurf on Google Email

Mayo Clinic


Mayo Clinic study shows loss of mental, functional abilities

Researchers discovered that many nonagenarians (people 90-99 years old) are free of Alzheimer's disease or dementia, with some performing in the superior range on cognitive tests. Mild cognitive impairment (MCI) also exists in this age group, but features similar characteristics to those seen in younger individuals.

SourceMayo Clinic·JournalNeurology·DateFeb 10, 2003

New evidence linking smoking and lung cancer in women

A Mayo Clinic study found that adenocarcinoma of the lung is more strongly associated with smoking than previously recognized. Women who smoked a pack of cigarettes a day for 20 to 39 years had a higher risk of developing lung cancer, particularly adenocarcinoma.

SourceMayo Clinic·JournalAmerican Journal of Epidemiology·DateDec 10, 2002

Mayo Clinic physicians look for cause of 'hot tub lung'

Mayo Clinic researchers identified Mycobacterium avium complex as the cause of 'hot tub lung', a previously poorly understood disease. The study found that warm temperatures and inadequate cleaning practices facilitate the growth of MAC in hot tub water, leading to respiratory problems.

SourceMayo Clinic·JournalMayo Clinic Proceedings·DateNov 12, 2002

Study shows first progress in heart-failure survival

A recent study from the Framingham Heart Study has shown a small but significant improvement in heart-failure survival rates since the 1990s. This increase is attributed to the widespread adoption of proven-effective medications such as beta-blockers, ACE inhibitors, and aldosterone antagonists. The findings suggest that treating patie...

SourceMayo Clinic·JournalNew England Journal of Medicine·DateOct 30, 2002

Type A and can’t handle it?

Researchers identified Kir6.2 as a protective mechanism against stress in the heart, which helps maintain equilibrium under peak workloads. The study found that mice lacking this protein experienced severe cardiac distress and died, while those with it survived stress tests.

SourceMayo Clinic·JournalProceedings of the National Academy of Sciences·DateSep 27, 2002

For the first time, drug shows promise to help spit tobacco users quit

A new study found that bupropion significantly improved abstinence rates among participants who used spit tobacco, with 44% quitting after 12 weeks compared to 26% in the placebo group. Additionally, participants taking bupropion gained less weight than those on the placebo, averaging only 1.54 pounds versus 9.7 pounds over the 12-week...

SourceMayo Clinic·JournalNicotine & Tobacco Research·DateSep 3, 2002

Mayo Clinic discovers one more downside to alcoholism

A recent study by Mayo Clinic researchers found that patients with alcoholic-liver disease are at a higher risk of developing confusion and delirium after liver transplant surgery. The study, which included 87 patients, revealed that the length of sobriety before surgery is directly correlated to the severity of these complications.

SourceMayo Clinic·JournalNeurology·DateAug 27, 2002

Mayo Clinic Proceedings features primers on medical genomics

The primer series provides a historical background of genetics and the sequencing of the human genome, as well as principles and methods in molecular biology. The authors highlight the potential benefits of the genomic revolution in understanding diseases such as cancer, heart disease, and Alzheimer's disease.

SourceMayo Clinic·JournalMayo Clinic Proceedings·DateAug 22, 2002

Detection of bioterrorism viruses brought closer to local sites

Mayo Clinic researchers have discovered a way to use autoclave sterilization procedures in laboratory settings to detect and confirm the identity of smallpox virus and other bioterrorism agents. This innovation enables local laboratories to conduct rapid tests, reducing the time needed to respond to potential attacks.

SourceMayo Clinic·JournalMayo Clinic Proceedings·DateJul 9, 2002

Mayo Clinic researchers find useful test for identifying patients

Mayo Clinic researchers have found a renewed use for a test to identify patients at risk of long QT syndrome, a genetic condition that can cause sudden death. The study used epinephrine infusion and electrocardiogram monitoring to detect a specific response in people with long QT syndrome 1, a subtype of the condition.

SourceMayo Clinic·JournalMayo Clinic Proceedings·DateMay 14, 2002

Mayo Clinic researchers develop 'cancer snitch'

Researchers at Mayo Clinic have developed a 'cancer snitch' - a genetically engineered virus that can track the progress of a viral treatment within a tumor. This non-invasive approach provides valuable feedback from within the body, allowing scientists to monitor biological activity and evaluate therapeutic effectiveness.

SourceMayo Clinic·JournalNature Medicine·DateMay 7, 2002

Mayo Clinic news briefs

A Mayo Clinic study finds an association between estrogen status and reduced coronary calcium and plaque area, suggesting a potential benefit against heart disease. Estrogen may modulate the calcium content of atherosclerotic plaques, slowing progression of atherosclerosis in women.

SourceMayo Clinic·JournalJournal of Endocrinology and Metabolism·DateMar 13, 2002

Mayo Clinic study defines patients at greater risk for developing multiple myeloma and related bone marrow cancers

The Mayo Clinic study found that the risk of progression from MGUS to multiple myeloma or related cancers is approximately one percent per year, with larger M-protein levels increasing the risk. Patients with very small protein levels had a 14% progression rate at 20 years, while those with high levels had a 60% progression rate.

SourceMayo Clinic·JournalNew England Journal of Medicine·DateFeb 22, 2002

Mayo Clinic Proceedings looks at epidemic of obesity in February issue

The study, conducted in Olmsted County, Minnesota, found that only a small percentage of people utilize recommended approaches to weight loss. The efforts being undertaken by CardioVision 2020 aim to reduce cardiovascular disease burden through diet and exercise changes. Meanwhile, another study on breast cancer patients highlights the...

SourceMayo Clinic·JournalMayo Clinic Proceedings·DateFeb 12, 2002

Antidepressant provides a cool choice for hot flashes

A recent study by Mayo Clinic researchers has confirmed that long-term use of venlafaxine provides women with breast cancer significant relief from hot flashes, with a 60% reduction in frequency over eight weeks. The antidepressant is considered a safe and effective non-hormonal alternative to estrogen for treating hot flashes.

SourceMayo Clinic·JournalOncology Nursing Forum·DateFeb 12, 2002

Marijuana-derived drug less effective than standard drug for improving appetite and weight in patients with advanced cancer

A study published by the Mayo Clinic found that megestrol acetate was more effective than dronabinol in improving appetite and weight loss in patients with advanced cancer. The study, which evaluated 469 patients, showed that 75% of those taking megestrol acetate reported appetite improvement, compared to 49% of those taking dronabinol.

SourceMayo Clinic·JournalJournal of Clinical Oncology·DateJan 25, 2002

Study finds that steroids soothe sore throat pain

Researchers found that steroid treatment reduced sore throat pain by four hours and increased relief to twice that of placebo patients. The study also showed significant cost savings due to the pill form, which eliminates the need for a physician or nurse to administer the shot.

SourceMayo Clinic·JournalThe Laryngoscope·DateJan 2, 2002